semaglutide no weight loss first month week of Results after 4 weeks on STARTING MY SEMAGLUTIDE JOURNEY *week Where Do You Lose Weight

This approach means taking your total weekly dose and breaking it into smaller, more frequent injections instead of one single shot

independence in older age decreases Bone Health: Muscle loss accelerates bone density decline and increases fall risk Blood Sugar: Muscle is the primary site of glucose uptakeless muscle means worse blood sugar control Weight Maintenance: People who lose significant muscle regain weight more easily after stopping GLP-1s Quality of Life: Lower energy, reduced physical capability, decreased confidence The reality is that GLP-1 medications are incredibly effective at creating a caloric deficitsometimes too effective

#ObesityManagement #GLP1 #OralSemaglutide #Pharmacotherapy #ClinicalPharmacy #SCOPECertified #BCPS #M42 #UAEHealthcare #WeightLossInnovation To view or add a comment, sign in 17,263 followers

Unlike insulin, which lowers blood sugar regardless of whether it needs lowering, GLP-1 receptor agonists only stimulate insulin release when glucose levels are actually high

A lower ratio means more stable levels, which theoretically translates to: Consistent therapeutic effect: Steady drug levels maintain continuous receptor activation Reduced side effects: Lower peak concentrations minimize adverse reactions Better tolerability: Gradual exposure allows physiological adaptation Mathematical modeling shows: Weekly dosing P/T ratio: ~3.5-4.0 Twice-weekly dosing P/T ratio: ~2.0-2.5 Daily dosing P/T ratio: ~1.2-1.5 Peak reduction with split dosing: 28-38% Trough increase with split dosing: 15-25% The Triple Agonist Complexity Retatrutide's unique triple mechanism adds layers of complexity to microdosing considerations: GLP-1 receptors: Rapid desensitization may benefit from lower, more frequent activation for sustained weight-loss effects GIP receptors: Different tissue distribution and kinetics than GLP-1 Glucagon receptors: Energy expenditure effects may vary with dosing pattern Receptor balance: Unknown how split dosing affects the ratio of receptor activation Lessons from Established Peptide Therapies Insulin: The Original Microdosing Success Insulin therapy provides the strongest precedent for peptide microdosing: Traditional Approach: NPH insulin twice daily High P/T ratios Frequent hypoglycemia Poor glycemic control Modern Microdosing: Basal-bolus regimens Continuous infusion pumps Stable glucose levels Reduced complications The shift from infrequent large doses to frequent small doses dramatically improved diabetes outcomes

In closing, its imperative to recognize that while aging is inevitable, the challenges it brings are not